Demand for bisphosphonates will increase through 2036, with oral delivery at 57.8% of the mode of delivery segment in 2026, driven by growing end-use demand and application expansion. The market was valued at USD 2.60 billion in 2025 and is expected to be worth USD 3.92 billion by 2036.